J
Jenny Jeyarajah
Researcher at National Center for Immunization and Respiratory Diseases
Publications - 30
Citations - 2694
Jenny Jeyarajah is an academic researcher from National Center for Immunization and Respiratory Diseases. The author has contributed to research in topics: Vaccination & Infliximab. The author has an hindex of 13, co-authored 29 publications receiving 2522 citations. Previous affiliations of Jenny Jeyarajah include Centers for Disease Control and Prevention & University of Western Ontario.
Papers
More filters
Journal ArticleDOI
National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years--United States, 2014.
Sarah Reagan-Steiner,David Yankey,Jenny Jeyarajah,Laurie D. Elam-Evans,James A. Singleton,C. Robinette Curtis,Jessica R. MacNeil,Lauri E. Markowitz,Shannon Stokley +8 more
TL;DR: Overall progress in vaccination coverage among adolescents, HPV vaccination coverage continues to lag behind Tdap and MenACWY coverage at state and national levels, but seven public health jurisdictions achieved significant increases in ≥1- or ≥3-dose HPV vaccination Coverage among females in 2014, demonstrating that substantial improvement in HPV vaccinations coverage is feasible.
Journal Article
Human papillomavirus vaccination coverage among adolescents, 2007-2013, and postlicensure vaccine safety monitoring, 2006-2014--United States.
Shannon Stokley,Jenny Jeyarajah,David Yankey,Maria Cano,Julianne Gee,Jill Roark,C. Robinette Curtis,Lauri E. Markowitz +7 more
TL;DR: Assessment of progress with HPV vaccination coverage among adolescents aged 13-17 years, characterize adherence with recommendations for HPV vaccination by the 13th birthday, and describe HPV vaccine adverse reports received postlicensure indicate that HPV4 is safe.
Journal Article
National and state vaccination coverage among adolescents aged 13-17 years--United States, 2012.
C. Robinette Curtis,David Yankey,Jenny Jeyarajah,Christina G. Dorell,Shannon Stokley,Jessica R. MacNeil,Susan Hariri +6 more
TL;DR: Large and increasing coverage differences between Tdap and other vaccines recommended for adolescents indicate that substantial missed opportunities remain for vaccinating teens, especially against HPV infection.
Journal ArticleDOI
National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years - United States, 2015.
Sarah Reagan-Steiner,David Yankey,Jenny Jeyarajah,Laurie D. Elam-Evans,C. Robinette Curtis,Jessica R. MacNeil,Lauri E. Markowitz,James A. Singleton +7 more
TL;DR: Despite limited progress, HPV vaccination coverage remained lower than MenACWY and tetanus, diphtheria, and acellular pertussis vaccine (Tdap) coverage, indicating continued missed opportunities for HPV-associated cancer prevention.
Journal Article
National, regional, state, and selected local area vaccination coverage among adolescents aged 13-17 years--United States, 2013.
Laurie D. Elam-Evans,David Yankey,Jenny Jeyarajah,James A. Singleton,Robinette C Curtis,Jessica R. MacNeil,Susan Hariri +6 more
TL;DR: Use of patient reminder and recall systems, immunization information systems, coverage assessment and feedback to clinicians, clinician reminders, standing orders, and other interventions can help make use of every health care visit to ensure that adolescents are fully protected from vaccine-preventable infections and cancers.